Kaleido Biosciences (KLDO) Competitors $0.0050 0.00 (0.00%) As of 04/24/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock KLDO vs. AGMH, OMQS, LFLY, ZPTA, FMTO, DMN, ELYS, BCAN, PRST, and GROMShould you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include AGM Group (AGMH), OMNIQ (OMQS), Leafly (LFLY), Zapata Computing (ZPTA), Femto Technologies (FMTO), Grafiti (DMN), Elys BMG Group (ELYS), BYND Cannasoft Enterprises (BCAN), Presto Automation (PRST), and Grom Social Enterprises (GROM). These companies are all part of the "computer software" industry. Kaleido Biosciences vs. AGM Group OMNIQ Leafly Zapata Computing Femto Technologies Grafiti Elys BMG Group BYND Cannasoft Enterprises Presto Automation Grom Social Enterprises AGM Group (NASDAQ:AGMH) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, community ranking, valuation, earnings and profitability. Which has more volatility and risk, AGMH or KLDO? AGM Group has a beta of 1.74, indicating that its share price is 74% more volatile than the S&P 500. Comparatively, Kaleido Biosciences has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500. Does the MarketBeat Community believe in AGMH or KLDO? AGM Group received 97 more outperform votes than Kaleido Biosciences when rated by MarketBeat users. Likewise, 58.75% of users gave AGM Group an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote. CompanyUnderperformOutperformAGM GroupOutperform Votes15158.75% Underperform Votes10641.25% Kaleido BiosciencesOutperform Votes5457.45% Underperform Votes4042.55% Do insiders & institutionals believe in AGMH or KLDO? 81.6% of Kaleido Biosciences shares are held by institutional investors. 34.9% of AGM Group shares are held by company insiders. Comparatively, 9.0% of Kaleido Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has preferable earnings and valuation, AGMH or KLDO? AGM Group has higher revenue and earnings than Kaleido Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAGM Group$65.00M0.02-$7.44MN/AN/AKaleido Biosciences$1.10M0.19-$95.48M-$2.240.00 Is AGMH or KLDO more profitable? Company Net Margins Return on Equity Return on Assets AGM GroupN/A N/A N/A Kaleido Biosciences N/A N/A N/A Does the media favor AGMH or KLDO? In the previous week, AGM Group had 1 more articles in the media than Kaleido Biosciences. MarketBeat recorded 1 mentions for AGM Group and 0 mentions for Kaleido Biosciences. AGM Group's average media sentiment score of 0.00 equaled Kaleido Biosciences'average media sentiment score. Company Overall Sentiment AGM Group Neutral Kaleido Biosciences Neutral SummaryAGM Group beats Kaleido Biosciences on 7 of the 9 factors compared between the two stocks. Get Kaleido Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLDO vs. The Competition Export to ExcelMetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$213,000.00$120.34M$5.44B$7.80BDividend YieldN/A3.69%5.43%4.31%P/E Ratio0.003.0022.1418.40Price / Sales0.194,221.41389.70101.29Price / CashN/A13.0238.2034.62Price / BookN/A34.746.664.18Net Income-$95.48M-$90.45M$3.21B$247.71M7 Day PerformanceN/A4.14%5.83%6.45%1 Month PerformanceN/A-1.27%-4.32%-3.14%1 Year PerformanceN/A93.66%17.83%5.40% Kaleido Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLDOKaleido BiosciencesN/A$0.01flatN/AN/A$213,000.00$1.10M0.0080Gap UpAGMHAGM Group0.6748 of 5 stars$0.03-5.8%N/A-96.3%$733,000.00$65.00M0.0020Positive NewsOMQSOMNIQN/A$0.07+12.3%N/A-83.6%$722,000.00$81.19M-0.03190LFLYLeafly1.3978 of 5 stars$0.16-33.2%$9.18+5,637.5%-89.9%$492,000.00$35.87M-0.07260Positive NewsZPTAZapata Computing1.2007 of 5 stars$0.00flat$1.63+115,971.4%-99.9%$54,000.00$5.68M0.0050FMTOFemto TechnologiesN/A$0.01-36.8%N/AN/A$35,000.00$998,839.000.00N/AHigh Trading VolumeDMNGrafitiN/A$0.00+23.5%N/AN/A$19,000.00$386,085.000.00N/AGap UpHigh Trading VolumeELYSElys BMG GroupN/A$0.00-60.0%N/A-99.7%$16,000.00$43.86M0.0090Gap DownBCANBYND Cannasoft EnterprisesN/A$0.02-35.8%N/A+611.7%$12,000.00$1.02M0.008Gap DownHigh Trading VolumePRSTPresto AutomationN/A$0.00+∞N/A-99.9%$10,000.00$19.05M0.004Gap UpGROMGrom Social EnterprisesN/A$0.00flatN/A-99.8%$9,000.00$3.72M0.00450News Coverage Related Companies and Tools Related Companies AGM Group Competitors OMNIQ Competitors Leafly Competitors Zapata Computing Competitors Femto Technologies Competitors Grafiti Competitors Elys BMG Group Competitors BYND Cannasoft Enterprises Competitors Presto Automation Competitors Grom Social Enterprises Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLDO) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
